Name | Number of supported studies | Average coverage | |
---|---|---|---|
dendritic cell | 3 studies | 26% ± 5% |
Insufficient scRNA-seq data for expression of GPR35 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 1754.10 | 966 / 966 | 98% | 50.32 | 515 / 527 |
stomach | 100% | 733.92 | 358 / 359 | 98% | 40.17 | 279 / 286 |
esophagus | 99% | 243.08 | 1428 / 1445 | 47% | 13.81 | 86 / 183 |
pancreas | 58% | 71.11 | 190 / 328 | 84% | 19.71 | 150 / 178 |
bladder | 100% | 243.14 | 21 / 21 | 39% | 14.21 | 199 / 504 |
lung | 100% | 276.07 | 576 / 578 | 34% | 5.49 | 395 / 1155 |
kidney | 99% | 371.03 | 88 / 89 | 34% | 3.16 | 305 / 901 |
ovary | 100% | 449.43 | 180 / 180 | 25% | 1.31 | 107 / 430 |
uterus | 100% | 433.64 | 170 / 170 | 25% | 3.42 | 114 / 459 |
brain | 98% | 259.73 | 2586 / 2642 | 19% | 0.77 | 134 / 705 |
thymus | 99% | 285.52 | 649 / 653 | 11% | 0.61 | 64 / 605 |
prostate | 100% | 406.61 | 244 / 245 | 5% | 0.24 | 24 / 502 |
breast | 97% | 222.85 | 444 / 459 | 6% | 0.25 | 65 / 1118 |
spleen | 100% | 820.33 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 449.97 | 914 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 197.95 | 1311 / 1335 | 0% | 0 | 0 / 0 |
adipose | 94% | 161.53 | 1137 / 1204 | 0% | 0 | 0 / 0 |
liver | 57% | 56.54 | 128 / 226 | 29% | 3.94 | 119 / 406 |
heart | 83% | 123.58 | 714 / 861 | 0% | 0 | 0 / 0 |
skin | 74% | 158.75 | 1331 / 1809 | 1% | 0.06 | 7 / 472 |
muscle | 63% | 71.98 | 508 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 51% | 49.40 | 132 / 258 | 1% | 0.06 | 3 / 230 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.62 | 4 / 29 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.37 | 5 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1901386 | Biological process | negative regulation of voltage-gated calcium channel activity |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0070098 | Biological process | chemokine-mediated signaling pathway |
GO_0035025 | Biological process | positive regulation of Rho protein signal transduction |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0007010 | Biological process | cytoskeleton organization |
GO_1904456 | Biological process | negative regulation of neuronal action potential |
GO_0005886 | Cellular component | plasma membrane |
GO_0016494 | Molecular function | C-X-C chemokine receptor activity |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
Gene name | GPR35 |
Protein name | G-protein coupled receptor 35 (Kynurenic acid receptor) (KYNA receptor) |
Synonyms | |
Description | FUNCTION: G-protein coupled receptor that binds to several ligands including the tryptophan metabolite kynurenic acid (KYNA), lysophosphatidic acid (LPA) or 5-hydroxyindoleacetic acid (5-HIAA) with high affinity, leading to rapid and transient activation of numerous intracellular signaling pathways . Plays a role in neutrophil recruitment to sites of inflammation and bacterial clearance through the major serotonin metabolite 5-HIAA that acts as a physiological ligand . Stimulates lipid metabolism, thermogenic, and anti-inflammatory gene expression in adipose tissue once activated by kynurenic acid (By similarity). In macrophages, activation by lysophosphatidic acid promotes GPR35-induced signaling with a distinct transcriptional profile characterized by TNF production associated with ERK and NF-kappa-B activation. In turn, induces chemotaxis of macrophages (By similarity). . |
Accessions | ENST00000407714.2 [Q9HC97-1] ENST00000438013.3 [Q9HC97-1] Q9HC97 ENST00000319838.10 [Q9HC97-1] ENST00000403859.1 [Q9HC97-1] ENST00000430267.2 [Q9HC97-2] |